This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Bourret, P. Search for Related Content Social Bookmarking                   What's this?

BRCA Patients and Clinical Collectives

New Configurations of Action in Cancer Genetics Practices

Université de la M éditerranée (Aix/Marseille II), INSERM Research Unit 379 (Social Science Applied to Medical Innovation) in Marseilles, pbourret{at}univ-aix.fr

Since the late 1980s, in France and in a number of other countries, cancer genetics testing has become a clinical reality, particularly for hereditary breast and ovarian cancer. BRCA tests allowing for the assessment of an increased cancer risk among patients and their healthy relatives are now being routinely performed as part of clinical practice. Based on fieldwork on French clinical cancer genetics and on the French Cancer Genetics Collaborative Network, this paper examines the configuration of entities, actors and activities mobilized by the performance of BRCA testing, and argues that the development of clinical molecular genetic practices is predicated upon the development of new forms of collaborative work that lead to a transformation of the content and organization of medical activities and judgements. The paper analyses three major collective configurations - local multidisciplinary collectives, data collectives and new clinical collectives - and argues that they not only provide the material conditions needed to carry out the relevant activities, but also articulate a series of distinctive bio-clinical interventions. These interventions provide an interface with research activities, produce the epidemiological measurements and tools that are a sine qua non for clinical work in this field, and, most importantly, establish the conventions that underlie practices, which define the criteria that turn tools and novel entities into operational components of clinical settings. It thus appears that in the field of clinical cancer genetics, bioclinical collectives, as a locus of expertise, have replaced the individual judgement of the practicing clinician.

Key Words: breast cancer • clinical guidelines • family patient • French cancer genetics • genetic testing • medical work

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. Lowy and J. P. Gaudilliere Localizing the Global: Testing for Hereditary Risks of Breast Cancer Science Technology Human Values, May 1, 2008; 33(3): 299 - 325. [Abstract] [PDF]

				L. Prior Talking About the Gene for Cancer: A Study of Lay and Professional Knowledge of Cancer Genetics Sociology, December 1, 2007; 41(6): 985 - 1001. [Abstract] [PDF]

				P. Bourret, A. Mogoutov, C. Julian-Reynier, and A. Cambrosio A New Clinical Collective for French Cancer Genetics: A Heterogeneous Mapping Analysis Science Technology Human Values, July 1, 2006; 31(4): 431 - 464. [Abstract] [PDF]